3D Bioprinting Market Scope
3D bioprinting market 2020 could accrue a valuation of USD 1,923.02 million by the year 2023, affirms Market Research Future (MRFR) in its extensive study. Moreover, the 3d bioprinting market size can expand at a significant rate of 24.59% during the analysis period (between 2018 and 2023).
3D Bioprinting Market Drivers and Restraints
3D bioprinting is a multifunction solution with a wide spectrum of applications, ranging from isolation wards to medical devices and even personal protection equipment. The technology is increasingly witnessing strong demand in view of the expanding supply and demand gap for medical devices resulted from the lockdown due to the pandemic. Logistical challenges arising in line with the travel bans and disruptions in manufacturing, coupled with the pushbacks to free trade have weakened the supply chains, resulting in lack of critical goods. As a result, the 3D bioprinting market’s growth rate has slowed down considerably in recent times. On the brighter side, 3D bioprinting technology’s digital versatility and fast prototyping properties that facilitate quick mobilization as well as real-time response to COVID-19 emergency have helped maintain its demand worldwide.
Get Free Sample of This Report at: https://www.marketresearchfuture.com/sample_request/869
3D bio printing’s significant applications include emergency dwellings, personal accessories, medical and testing devices, personal protective equipment (PPE), visualization aids, and more. The technology also provides training and visualization aid to healthcare professionals, which helps overcome the challenge of dearth of skilled personnel. Companies are competing with each other for a higher share in the market, by adopting strategies like new launches, agreements and partnerships. For instance, in August 2020, Isinnova, a reputed engineering firm in Italy, designed a 3D-printable mask connector known as Charlotte valve that connects Decathlon’s Easybreath snorkelling masks with CPAP machines.
Organ transplantation is another growth rendering factor in the global market, as it requires extensive use of the 3D bioprinting technology. Soaring incidences of various chronic diseases have also fostered the urgent need for effective organ and tissue transplants, which assists in market growth. Cost-effectiveness of 3D bioprinting combined with the escalating deployment of small prosthetics as well as implants for the treatment of dental or craniofacial disorders also add to the market value.
3D Bioprinting Market Segmental Analysis
The 3D bioprinting market has been considered for technology, material, application, and end-user.
Technologies analyzed in the report are microextrusion bioprinting, inkjet 3D bioprinting, magnetic 3D bioprinting and laser-assisted bioprinting. The inkjet 3D bioprinting market is growing relatively better than its counterparts and can continue to scale steadily during the given period.
Material-based market segments are hydrogels, living cells and extracellular matrices.
Top application areas of 3D bioprinting include research along with clinical applications.
End-users that are prominent in the global market for 3D bioprinting are research organizations & academic institutes along with pharmaceutical & biotechnology companies.
Complete report is available @ https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=869
3D Bioprinting Market Regional Outlook
The regional distribution of the 3D bioprinting market covers Europe, the Middle East & Africa (MEA), Asia Pacific (APAC), as well as the Americas.
In 2017, the American market clinched the top position in view of the mounting use of 3D products, the burgeoning pool of additive manufacturers and the excellent financial condition of the patients. Moreover, the recent COVID-19 pandemic has bolstered the need to develop vaccine and has raised the focus on drug testing, which has made scientists extensively use the 3D bio-printing technology to conduct preclinical trials. Likewise, a number of biotherapeutic vendors in the region are utilizing the technology for conducting novel coronavirus-based researches. For instance, in August 2020, Viscient Biosciences had used the 3D bioprinting technology for the development of a lung tissue for conducting an exhaustive viral infectivity study. The company also explored a potential therapy that could work against the SARS-CoV-2 infection.
Asia Pacific could attain the fastest CAGR in the next couple of years, as a result of the fast-expanding healthcare sectors in China and India. Rising spending on R&D activities paired with the dramatic increase in mortality rate since the COVID-19 outbreak also push the market demand in the region. Lower number of organ donors also strengthen the 3D bioprinting market’s position in the region while the emerging popularity of the magnetic levitation technology for healthcare applications in human cell regeneration, toxicity screening and vascular muscle printing has led to significant business growth.
3D Bioprinting Market Key Companies
Affluent firms in the 3d bioprinting industry are REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), Regenovo Biotechnology Co. Ltd. (China), EnvisionTEC GmbH (Germany), Allevi (U.S.), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), FUJIFILM Wako Automation Corporation (U.S.), Cellink AB (Sweden), Organovo Holdings Inc. (U.S.), Cyfuse Biomedical K.K. (Japan), Poietis (France), to mention a few.
Table Of Content
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition 20
3.2 Scope Of The Study 20
3.3 Research Objective 20
3.4 Assumptions & Limitations 20
3.4.1 Assumptions 20
3.4.2 Limitations 20
3.5 Market Structure 21
3.6 Research Process 21
4 Research Methodology
4.1 Primary Research 24
4.2 Secondary Research 25
4.3 Market Size Estimation 26
4.4 Forecast Model 26
5 Market Dynamics
5.1 Introduction 28
5.2 Drivers 28
5.2.1 Growing Demand For Organ Transplantation 28
5.2.2 Cost-Efficiency Of 3D Bioprinting 28
5.2.3 Growing Focus Of Market Players On 3D Bioprinting 29
5.2.4 Increasing Funding And Investments For Research 29
5.3 Restraints 29
5.3.1 Lack Of Awareness Regarding 3D Bioprinting 29
5.3.2 Lack Of Skilled Professionals 29
5.4 Opportunities 30
5.4.1 Dominance Of Start-Ups 30
Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
For More See Healthcare Related Reports:
Cystic Fibrosis Market Research Report – Global Forecast till 2027
Cell Culture Media Market Research Report – Global Forecast till 2027
M-Health Device Market Research Report – Global Forecast till 2027
Ticagrelor Market Research Report – Global Forecast till 2027
Clinical Laboratory Test Market Research Report – Global Forecast till 2027
Orthokeratology Lens Market Research Report – Global Forecast till 2027
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.